Plain Language Summary: Immunotherapy for Inhalant Allergy.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 38408155.
- Also identified by DOI 10.1002/ohn.649.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The plain language summary explains allergen immunotherapy to patients, families, and caregivers. The summary is for patients aged 5 years and older who are experiencing symptoms from inhalant allergies and are considering immunotherapy as a treatment option. It is based on the 2024 "Clinical Practice Guideline: Immunotherapy for Inhalant Allergy." This plain language summary is a companion publication to the full guideline, which provides greater detail for health care providers. Guidelines and their recommendations may not apply to every patient, but they can be used to find best practices and quality improvement opportunities.
Medical subject headings
- Hypersensitivity
- Rhinitis, Allergic